On this page
Back to topTRex Bio TRXB
TRex Bio listed on Nasdaq on 9 Oct 2026 and is not in the S&P 500. It is worth $280 million. Its price history starts on 9 Oct 2026. Its board is not in our data yet.
- Listed
- 9 Oct 2026 on Nasdaq, IPO filings and terms
- Headquarters
- South San Francisco, CA
- Market cap
- $280M
- 19 Nov 2026 close
- Revenue
- -
- No annual report yet
Financials
TRex Bio's market cap
TRex Bio was worth $400M at the end of its first week of trading, on 9 Oct 2026, and is worth $280M now.
Board and leadership
Board and officers
TRex Bio's board is not in our data yet. It listed on 9 Oct 2026 and has not filed a proxy statement. See its 8-K filings.
Not on file: no open-market insider buys or sales in the 12 months to 19 Nov 2026, no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet, no earnings release figures from the last six months, no quarterly results in its SEC XBRL filings and no director or officer changes, WARN notices or large insider sales in the last two years. 13F holdings: TRex Bio listed after the last quarter (30 Jun 2026). The next 13F filings were due by 14 Nov 2026.